SYZ enters its May 14 results with the market distracted by something more immediately combustible than quarterly numbers — a proxy fight that has drawn in the company's largest shareholder and sent insiders scrambling to buy stock at depressed levels.
The proxy contest is the dominant narrative right now. OneMove Capital, which disclosed a 14.98% stake in March, published a "comprehensive plan" on April 22 calling out what it described as 75% value destruction under the incumbent board. Two days later, a pointed open letter raised seven questions for CEO Tyler Proud. The company filed its management information circular mid-April, setting the stage for a shareholder vote at the annual and special meeting. That contest is arriving against a backdrop of a stock that fell 9.4% on the week to CAD 3.85 — though it has recovered 6.9% over the past month from deeper lows.
The borrow market tells the clearest short story. Availability has effectively collapsed: the lending pool is nearly fully consumed, with almost every share that can be lent already out on loan. That leaves virtually no slack for new short positions to be added without driving up borrowing costs, and cost to borrow has been running between 5% and 6% APR for most of the past month — briefly spiking to 7.55% on April 6 before settling back. Short interest itself is running at approximately 6.7% of free float, broadly flat over the past month but up a touch on the week. The ORTEX short score has crept up to 70.6 out of 100, its highest reading in the recent window, and the stock's utilization rank places it in the bottom percentile of the universe. All of that adds up to a borrow market under significant stress — not newly so, but persistently so.
Insiders are voting with their wallets in the opposite direction. The 90-day net buying position amounts to roughly 1.24 million shares worth approximately CAD 4.7 million at current prices. The most significant single move was SEASTONE INVEST LTD — the vehicle behind the OneMove Capital stake — buying just under 1 million shares on March 24 at CAD 3.80 per share, a transaction worth nearly CAD 3.8 million. Director Andrew Shen added a further 199,100 shares on April 16 at CAD 3.72, and independent director Errol Olsen bought 24,000 shares at CAD 3.30 on April 8. The cluster of buying from both the activist and the board itself, all at prices close to or below current levels, is the most concentrated insider-demand signal the stock has shown in recent memory.
The analyst picture offers limited fresh guidance. The consensus sits at "hold" with three buys and three holds, and the mean price target of CAD 5.25 implies meaningful upside from CAD 3.85 — but the analyst data is over 40 days old and pre-dates the sharpest leg of the recent selloff, so that target should be read cautiously. Valuation is relatively undemanding: the EV/EBITDA multiple has compressed to 10.1x, down about half a turn over the past month, while the trailing P/E of 30x reflects the modest earnings base rather than a premium rating. The dividend history shows the company reinstated only a token CAD 0.01 payout in February after paying out CAD 0.125 quarterly through 2021 and 2022 — a reminder of how far the shareholder returns story has been walked back.
Earnings history adds one more data point worth watching. The April 9 print triggered a 2.9% next-day gain followed by a 23.2% five-day rally — the most significant post-earnings move in the recent record. The March 19 result delivered a muted 1.8% pullback. With the proxy vote outstanding and the May 14 print approaching, the interaction between earnings quality and the governance dispute will set the tone for what comes next.
See the live data behind this article on ORTEX.
Open SYZ on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
